CPA: leucopenia · SSNS in children
Alkylating agents led to higher CPA: leucopenia compared with steroids, placebo or both; GRADE not reported.
1 finding from 1 review
RR 10.63 [1.45, 78.05]
Studies not reported
GRADE not reported
Chlorambucil: leucopenia · SSNS in children
Alkylating agents showed no clear difference in chlorambucil: leucopenia compared with steroids, placebo or both; GRADE not reported.
1 finding from 1 review
RR 2.5 [0.11, 54.87]
Studies not reported
GRADE not reported
Adverse effects: leucopenia · SSNS in children
Intravenous showed no clear difference in adverse events: leucopenia compared with oral cyclophosphamide (low certainty).
1 finding from 1 review
Adverse effects: lymphopenia · SSNS in children
Cyclophosphamide may leads to lower adverse effects: lymphopenia compared with chlorambucil (low certainty).
1 finding from 1 review
Thrombocytopenia · SSNS in children
Cyclophosphamide may leads to lower adverse effects: thrombocytopenia compared with chlorambucil (low certainty).
1 finding from 1 review
Intervention not reported
Atropine plus bifocal spectacles vs cyclopentolate plus SVLs · children with myopia (nearsightedness)
1 finding from 1 review
Safety (AE, adverse drug reaction): thrombocytopenia Grades 3 or 4 according to National Cancer Institute · combination with third‐generation drugs for advanced non‐small cell lung cancer
Carboplatin probably leads to higher grade III or IV thrombocytopenia compared with cisplatin chemotherapy (moderate certainty).
1 finding from 1 review
Thrombocytopenia · CRRT
It is very uncertain whether unfractionated heparin changes thrombocytopenia compared with low molecular weight heparin (very low certainty).
1 finding from 1 review
Thrombocytopenia · CRRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thrombocytopenia · CRRT
Citrate showed no clear difference in thrombocytopenia compared with unfractionated heparin (low certainty).
1 finding from 1 review
Presence of osteopenia · people with CAH
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Presence of osteopenia · people with CAH
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Presence of osteopenia · people with CAH
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Presence of osteopenia · people with CAH
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Heparin‐induced thrombocytopaenia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Lymphopenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in lymphopenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
Neutropenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in neutropenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
Thrombocytopenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in thrombocytopenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
Adverse events: clinically relevant non‐major bleeding / heparin‐induced thrombocytopenia ‐ not reported · adults with acute lymphoblastic leukaemia treated with asparaginase‐based chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Presence of osteopenia · promoting growth and development in very low birth weight infants receiving human milk
It is very uncertain whether targeted or adjustable individualized fortification changes osteopenia compared with standard non‐individualized fortification (very low certainty).
1 finding from 1 review